Serum amyloid a protein in inflammation and obesity

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/53 (2006.01)

Patent

CA 2589277

The present invention relates to the discovery that acute-phase serum amyloid protein A (A-SAA) is a biomarker for obesity and certain abnormal conditions. The present invention, therefore, provides methods of diagnosing obesity or an abnormal condition in a subject The present invention also provides methods of monitoring the progression of obesity or an abnormal condition in a subject. The present invention also relates to treating obesity or an abnormal condition comprising reducing the levels of active SAA1 and/or SAA2 in a subject in need thereof.

L'invention concerne la découverte que la protéine sérum amyloïde A de phase aiguë (A-SAA) est un biomarqueur pour l'obésité et certains états anormaux. Par conséquent, l'invention concerne des méthodes permettant de diagnostiquer l'obésité ou un état anormal chez un sujet. L'invention concerne également des méthodes permettant de surveiller le progrès de l'obésité ou d'un état anormal chez un sujet. Enfin, l'invention concerne un traitement de l'obésité ou d'un état anormal qui consiste à réduire les taux de SAA1 active et/ou de SAA2 active chez un sujet nécessitant un tel traitement.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Serum amyloid a protein in inflammation and obesity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Serum amyloid a protein in inflammation and obesity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Serum amyloid a protein in inflammation and obesity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1408168

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.